These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 11596277)

  • 1. [Synthesis and biological activity of tyrosine protein kinase inhibitors].
    Pang SH; Guo ZR; Liang XT
    Yao Xue Xue Bao; 1997 Jul; 32(7):515-23. PubMed ID: 11596277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of quercetin on activities of protein kinase C and tyrosine protein kinase from HL-60 cells.
    Kang TB; Liang NC
    Zhongguo Yao Li Xue Bao; 1997 Jul; 18(4):374-6. PubMed ID: 10072927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, structure-activity relationship, and p210(bcr-abl) protein tyrosine kinase activity of novel AG 957 analogs.
    Kaur G; Narayanan VL; Risbood PA; Hollingshead MG; Stinson SF; Varma RK; Sausville EA
    Bioorg Med Chem; 2005 Mar; 13(5):1749-61. PubMed ID: 15698792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of quercetin on cultured neonatal rat cardiomyocytes hypertrophy induced by angiotensin.
    Qin TC; Chen L; Yu LX; Gu ZL
    Acta Pharmacol Sin; 2001 Dec; 22(12):1103-6. PubMed ID: 11749808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of tyrosine protein kinase associated with subcellular components of human colonic epithelium.
    Schwartz B; Cagnano E; Braun S; Lamprecht SA
    Anticancer Res; 1990; 10(6):1747-53. PubMed ID: 2285253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a novel and potent series of dianilinopyrimidineurea and urea isostere inhibitors of VEGFR2 tyrosine kinase.
    Sammond DM; Nailor KE; Veal JM; Nolte RT; Wang L; Knick VB; Rudolph SK; Truesdale AT; Nartey EN; Stafford JA; Kumar R; Cheung M
    Bioorg Med Chem Lett; 2005 Aug; 15(15):3519-23. PubMed ID: 15990302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effects of genistein on tyrosine protein kinase-mitogen activated protein kinase signal transduction pathway in hypertrophic scar fibroblasts].
    Cao C; Li SR; Dai X; Chen YQ; Feng Z; Qin X; Zhao Y; Wu J
    Zhonghua Shao Shang Za Zhi; 2008 Apr; 24(2):118-21. PubMed ID: 18785412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening enzyme-inhibitory activity in several ascidian species from Orkney Islands using protein tyrosine kinase (PTK) bioassay-guided fractionation.
    Barenbrock JS; Köck M
    J Biotechnol; 2005 May; 117(3):225-32. PubMed ID: 15862352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular design and biological activity of BCR-ABL tyrosine kinase inhibitors].
    Peng H; Qi J; Huang N; Xie P; Wang JX; Yang CZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):145-9. PubMed ID: 15171550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein-acrylamide copolymer hydrogels for array-based detection of tyrosine kinase activity from cell lysates.
    Brueggemeier SB; Wu D; Kron SJ; Palecek SP
    Biomacromolecules; 2005; 6(5):2765-75. PubMed ID: 16153117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of peanut serine/threonine/tyrosine protein kinase: molecular docking and inhibition kinetics with tyrosine kinase inhibitors.
    Rudrabhatla P; Rajasekharan R
    Biochemistry; 2004 Sep; 43(38):12123-32. PubMed ID: 15379551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of benzamides and benzamidines as selective inhibitors of VEGFR tyrosine kinases.
    Nakamura H; Sasaki Y; Uno M; Yoshikawa T; Asano T; Ban HS; Fukazawa H; Shibuya M; Uehara Y
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5127-31. PubMed ID: 16893647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of 7H-pyrrolo[2,3-d]pyrimidines as focal adhesion kinase inhibitors. Part 1.
    Choi HS; Wang Z; Richmond W; He X; Yang K; Jiang T; Sim T; Karanewsky D; Gu XJ; Zhou V; Liu Y; Ohmori O; Caldwell J; Gray N; He Y
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2173-6. PubMed ID: 16458503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of inhibitors for protein tyrosine kinases.
    Al-Obeidi FA; Lam KS
    Oncogene; 2000 Nov; 19(49):5690-701. PubMed ID: 11114749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salicylanilides as inhibitors of the protein tyrosine kinase epidermal growth factor receptor.
    Liechti C; Séquin U; Bold G; Furet P; Meyer T; Traxler P
    Eur J Med Chem; 2004 Jan; 39(1):11-26. PubMed ID: 14987830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibitory effect of BSP-A1/-A2 on protein kinase C and tyrosine protein kinase.
    Yu B; Zhao Y; Zhao W; Chen F; Liu Y; Zhang J; Fu W; Zong Z; Yu A; Guan Y
    Cell Biochem Funct; 2003 Jun; 21(2):183-8. PubMed ID: 12736909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of trans-3,4'-bispyridinylethylenes as potent and novel inhibitors of protein kinase B (PKB/Akt) for the treatment of cancer: Synthesis and biological evaluation.
    Li Q; Li T; Zhu GD; Gong J; Claibone A; Dalton C; Luo Y; Johnson EF; Shi Y; Liu X; Klinghofer V; Bauch JL; Marsh KC; Bouska JJ; Arries S; De Jong R; Oltersdorf T; Stoll VS; Jakob CG; Rosenberg SH; Giranda VL
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1679-85. PubMed ID: 16403626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The design and preliminary structure-activity relationship studies of benzotriazines as potent inhibitors of Abl and Abl-T315I enzymes.
    Cao J; Fine R; Gritzen C; Hood J; Kang X; Klebansky B; Lohse D; Mak CC; McPherson A; Noronha G; Palanki MS; Pathak VP; Renick J; Soll R; Zeng B; Zhu H
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5812-8. PubMed ID: 17827012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and structure-activity relationship of heterocyclic analogs of 4-amino-3-benzimidazol-2-ylhydroquinolin-2-ones as inhibitors of receptor tyrosine kinases.
    Frazier K; Jazan E; McBride CM; Pecchi S; Renhowe PA; Shafer CM; Taylor C; Bussiere D; He MM; Jansen JM; Lapointe G; Ma S; Vora J; Wiesmann M
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2247-51. PubMed ID: 16446087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and pharmacological evaluation of novel beta-nitrostyrene derivatives as tyrosine kinase inhibitors with potent antiplatelet activity.
    Wang WY; Hsieh PW; Wu YC; Wu CC
    Biochem Pharmacol; 2007 Aug; 74(4):601-11. PubMed ID: 17601492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.